Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055485
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $8.88K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+142$3.34+$474.2834,973Direct
Aug 3, 2021Common StockPPurchaseAcquired+142$3.17+$450.1435,115Direct
Aug 4, 2021Common StockPPurchaseAcquired+142$3.18+$451.5635,257Direct
Aug 5, 2021Common StockPPurchaseAcquired+142$3.11+$441.6235,399Direct
Aug 6, 2021Common StockPPurchaseAcquired+142$3.01+$427.4235,541Direct
Aug 9, 2021Common StockPPurchaseAcquired+142$2.93+$416.0635,683Direct
Aug 10, 2021Common StockPPurchaseAcquired+142$2.96+$420.3235,825Direct
Aug 11, 2021Common StockPPurchaseAcquired+142$2.98+$423.1635,967Direct
Aug 13, 2021Common StockPPurchaseAcquired+142$2.92+$414.6436,109Direct
Aug 16, 2021Common StockPPurchaseAcquired+142$2.92+$414.6436,251Direct
Aug 17, 2021Common StockPPurchaseAcquired+142$3.05+$433.136,393Direct
Aug 18, 2021Common StockPPurchaseAcquired+142$2.97+$421.7436,535Direct
Aug 19, 2021Common StockPPurchaseAcquired+142$3.02+$428.8436,677Direct
Aug 20, 2021Common StockPPurchaseAcquired+142$2.96+$420.3236,819Direct
Aug 23, 2021Common StockPPurchaseAcquired+142$2.87+$407.5436,961Direct
Aug 24, 2021Common StockPPurchaseAcquired+142$2.89+$410.3837,103Direct
Aug 25, 2021Common StockPPurchaseAcquired+142$2.79+$396.1837,245Direct
Aug 26, 2021Common StockPPurchaseAcquired+142$2.82+$400.4437,387Direct
Aug 27, 2021Common StockPPurchaseAcquired+142$2.84+$403.2837,529Direct
Aug 30, 2021Common StockPPurchaseAcquired+142$2.88+$408.9637,671Direct
Aug 31, 2021Common StockPPurchaseAcquired+142$2.93+$416.0637,813Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)